Zacks_SCR_Research_08242022_EDSA_Bautz.pdf (q4cdn.com)
JP Morgan Downgrades Bioventus to Underweight
JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.
Zacks Small-Cap Research Sets $15 Valuation On Edesa Biotech
Zacks_SCR_Research_08242022_EDSA_Bautz.pdf (q4cdn.com)
Related Posts
Bitcoin, Ethereum Record Losses Following PPI Data; Pepe Becomes Top Loser
Bitcoin (CRYPTO: BTC) moved lower, with the cryptocurrency prices trading below the key $28,000 level on Thursday.
Ethereum (CRYPTO: ETH) also traded lower, but remained above the key $1,800 mark this morning.
Rivian Recalls Nearly All Of EVs Deliveries To-Date Due to Fastener Issue
Rivian Automotive, Inc.’s (NASDAQ: RIVN) otherwise good week ended with some bad tidings for the electric vehicle manufacturer.